Travere Therapeutics (TVTX) EBITDA Margin (2013 - 2026)
Travere Therapeutics' EBITDA Margin came in at -28.01% for Q3 2026, down 52.71 percentage points from 24.70% a year earlier and down 32.84 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) EBITDA Margin (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Travere Therapeutics reported EBITDA Margin of -12.40%, down 4.04 percentage points year-over-year; for FY2025, it was -0.09%, up 119.37 percentage points from FY2024.
- EBITDA Margin has increased in each of the last three years, with a five-year change of +71.06 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -119.46% in FY2024 (+120.07 pp), -239.53% in FY2023 (+32.23 pp) and -271.76% in FY2022.
- The Q3 2026 figure represents the lowest quarterly EBITDA Margin since Q1 2025.
- Year-over-year, EBITDA Margin increased in seven of the last eight quarters, with an average year-over-year change of +79.34 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2022 (a gain of 475.66 percentage points), and the weakest in Q4 2021 (a drop of 533.96 percentage points).
- Business Quant data shows TVTX's EBITDA Margin at 4.83% (Q2 2026), -9.20% (Q1 2026) and -11.02% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Travere Therapeutics | 4.85 Bn | 4.44 Bn | 221.70 Mn | -28.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -28.01% |
| Jun 30, 2026 | 4.83% |
| Mar 31, 2026 | -9.20% |
| Dec 31, 2025 | -11.02% |
| Sep 30, 2025 | 24.70% |
| Jun 30, 2025 | 1.19% |
| Mar 31, 2025 | -36.55% |
| Dec 31, 2024 | -65.05% |
| Sep 30, 2024 | -71.40% |
| Jun 30, 2024 | -105.99% |
| Mar 31, 2024 | -312.65% |
| Dec 31, 2023 | -188.08% |
| Sep 30, 2023 | -218.65% |
| Jun 30, 2023 | -288.87% |
| Mar 31, 2023 | -293.80% |
| Dec 31, 2022 | -272.55% |
| Sep 30, 2022 | -295.53% |
| Jun 30, 2022 | -244.43% |
| Mar 31, 2022 | -275.72% |
| Dec 31, 2021 | -748.21% |
API Access
Travere Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();